[ RECIPIENT ENTITY RECORD ]

Prometheus Biosciences Inc.

VERIFIED NODE ID: 002033 · prometheus-biosciences-inc
R TARGET NODE — CAPITAL RECIPIENT
Prometheus Biosciences Inc.
Company United States
Recipient Type
Company
Primary Jurisdiction
United States
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name Prometheus Biosciences Inc.
Entity Type Company
Jurisdiction United States
Recipient Intelligence Summary

Prometheus Biosciences is a biotechnology company that utilizes a precision medicine platform for the treatment of immune-mediated diseases like inflammatory bowel disease. Based in California, the firm specializes in gastrointestinal therapies. It was a primary destination for institutional healthcare capital in a high-value pharmaceutical acquisition.

Capital Influx Log (Transactions)
Date Type Amount
23 May 2026 EQUITY $10.8B